| Literature DB >> 32878348 |
Raquel L Silva1, Daniel P Demarque1, Renata G Dusi1, João Paulo B Sousa1, Lorena C Albernaz1, Laila S Espindola1.
Abstract
The number of documented dengue cases has increased dramatically in recent years due to transmission through the Aedes aegypti mosquito bite. Vector control remains the most effective measure to protect against this and other arboviral diseases including Zika, chikungunya and (urban) yellow fever, with an established vaccine only available for yellow fever. Although the quinone class shows potential as leading compounds for larvicide development, limited information restricts the development of optimized structures and/or formulations. Thus, in this contribution we investigated the larvicidal and pupicidal activity of three quinone compounds isolated from a Connarus suberosus root wood ethyl acetate extract together with 28 quinones from other sources. Eight quinones demonstrated larvicidal activity, of which tectoquinone (4) proved to be the most active (LC50 1.1 µg/mL). The essential residual effect parameter of four of these quinones was evaluated in laboratory trials, with tectoquinone (4) and 2-ethylanthraquinone (7) presenting the most prolonged activity. In small-scale field residual tests, tectoquinone (4) caused 100% larvae mortality over 5 days, supporting its selection for formulation trials to develop a prototype larvicide to control Ae. aegypti.Entities:
Keywords: Aedes aegypti; Connarus suberosus; embelin; quinones; residual larvicidal activity; tectoquinone
Mesh:
Substances:
Year: 2020 PMID: 32878348 PMCID: PMC7504811 DOI: 10.3390/molecules25173978
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Quinone derivatives 1–31: (1) suberonone; (2) rapanone; (3) embelin; (4) tectoquinone; (5) emodin; (6) plumbagin; (7) 2-ethylanthraquinone; (8) 1-chloroanthraquinone; (9) anthrone; (10) 2-(4-pyridil)-1H-anthra[1,2-d]imidazole-6,11-dione; (11) krisolamine; (12) anthraquinone-2-carboxylic acid; (13) 4,5-dinitrochrysazin; (14) 1-aminoanthraquinone; (15) 5,7,12,14-pentacenetetrone; (16) anthrarufin; (17) sodium anthraquinone-2-sulfonate; (18) anthraquinone; (19) bromaminic acid; (20) 2-phenylanthraquinone; (21) alizarin; (22) quinizarin; (23) rhein; (24) 1-amino-4-hydroxyanthraquinone; (25) 2-aminoanthraquinone; (26) 1,5-diaminoanthraquinone; (27) dibromoaminoanthraquinone; (28) 1,4-bis(methylamino)anthraquinone; (29) 1,8-dichloroanthraquinone; (30) 1,5-dichloroanthraquinone and (31) diacerein. C-glycoside derivative of gallic acid: (32) bergenin. All compounds tested against Ae. aegypti larvae at 25 µg/mL. LC50 values were only determined for compounds causing ≥80% mortality after 24 h (2–9). * Compounds with mortality percentages < 80% after 24 h.
LC50 (µg/mL) and LC90 (µg/mL) data for compounds 2–9.
| Compound | Concentration | a FV | b n | c N | LC50 µg/mL | LC90 µg/mL |
|---|---|---|---|---|---|---|
|
| 200; 100; 50; 25; 12.5 | 3 | 600 | 12 | 72.62 * (65.27–81.02) | >200.0 * |
|
| 50; 25; 20; 15; 10; 5 | 20 | 1800 | 12 | 23.51 * (22.12–25.16) | 48.36 * (40.66–>50.0) |
|
| 3.5; 1.75; 0.88; 0.44; 0.22; 0.11 | 120 | 1800 | 12 | 1.10 * (1.04–1.17) | 2.11 * (1.86–2.39) |
|
| 50; 25; 12.5; 6.25; 3.13; 1.56 | 20 | 1800 | 12 | 4.99 * (4.52–5.50) | 10.05 * (8.31–12.13) |
|
| 25; 12.5; 6.25; 3.13; 1.56; 0.78 | 20 | 1800 | 12 | 6.52 * (6.17–6.88) | 12.70 * (11.18–14.39) |
|
| 10; 4; 1.6; 0.64; 0.26; 0.10 | 120 | 1800 | 12 | >10.0 * | >10.0 * |
|
| 10; 1; 0.1; 0.01 | 120 | 1200 | 12 | >10.0 * | >10.0 * |
|
| 150; 37.5; 9.38; 2.34; 0.59; 0.5 | 120 | 1800 | 12 | 12.87 * (10.13–16.38) | >150.0 * |
|
| 0.025; 0.0125; 0.00625; 0.003125; 0.0015625 | 120 | 1500 | 12 | 0.0081 * (0.0076–0.0085) | 0.0130 * (0.0117–0.0144) |
a FV: final volume. b n: number of larvae. c N: number of replicates. d CI: lower/upper confidence interval. DMSO (negative control)—larvae mortality < 20%. According to the WHO guideline, tests with control mortality > 20% were discarded.
Figure 2(a) Tectoquinone (4) laboratory residual larvicide effect after 20 days. Larvae mortality was recorded after 24 h, with larvae replaced every 24 h. (b) 2-ethylanthraquinone (7) laboratory residual larvicide effect after 8 cycles of 72 h. Larvae mortality was recorded after 24 h, with larvae replaced every 72 h. (c) Anthrone (9) laboratory residual larvicide effect after 4 days. Larvae mortality was recorded after 24 h, with larvae replaced every 24 h. (d) 1-chloroanthraquinone (8) laboratory residual larvicide effect after 3 cycles of 72 h. Larvae mortality was recorded after 24 h, with larvae replaced every 72 h. Error bars = standard error of the mortality mean value. DMSO (negative control) mortality <5%. Temephos (positive control) mortality decreased from 96% (Day 1) to 68% (Day 4) and to <48% (Day 9).
Figure 3Tectoquinone (4; 2.1 µg/mL, 3.5 µg/mL and 4.3 µg/mL) small-scale field residual larvicide effect over 6 days. Larvae mortality was recorded every 24 h, with daily larvae replacement. DMSO (negative control) mortality < 5%. Temephos (positive control) mortality decreased from 99% (Day 1) to 85% (Day 6) and to <56% (Day 9). Error bars = standard error of the mortality mean value.